Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$165,000.00

The role of filamin A in osteoclastogenesis

EF 2008-09

Résumé
Osteoclasts are bone-resorbing cells derived from progenitors that differentiate and subsequently fuse. They are essential in normal physiologic bone turnover; however, they also destroy bone in osteoporosis, rheumatoid arthritis, and periodontal disease. Osteoclastogenesis (osteoclast formation) involves migration of precursor cells followed by cell fusion, both processes requiring a dynamic actin cytoskeleton. The protein filamin A has been shown in other cell types to control the actin cytoskeleton and cell migration, thus it may play a crucial role in osteoclastogenesis as well. Bisphosphonates are the current drug of choice to treat pathological bone destruction by inhibiting osteoclastogenesis, thus slowing down bone destruction and disease progression. However, due to impaired bone turnover and the resultant alteration in normal bony architecture, significant side effects of bisphosphonate therapy include poor bone healing and osteonecrosis (death of the bone) following traumatic events such as bone fractures and tooth extractions, leading to great morbidity, pain, and decreased quality of life. These clinical findings highlight the importance of my proposed research project. The role of filamin A in osteoclastogenesis has not been studied in the literature. The goal of my project is to delineate components of the filamin A signaling cascade during osteoclast formation. Our lab has bred mice with osteoclast progenitors that genetically lack filamin A. We have also developed a well-characterized 6 day model to grow osteoclasts from these mice. Using these resources I will delineate the filamin A signaling cascade during the migration and fusion stages of osteoclastogenesis, including its localization, temporal expression, and interaction with other signaling proteins. With better understanding of how filamin A regulates osteoclastogenesis, new drug targets may be identified to treat pathological bone resorption with reduced side effects.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
185813
Name
Leung Roland
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
The role of filamin A in osteoclastogenesis
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$165,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell Fusion; Cell Migration; Cell Signalling; Filamin A; Monocyte; Osteoclast; Rho Family Gtpases
Abstract
Osteoclasts are bone-resorbing cells derived from progenitors that differentiate and subsequently fuse. They are essential in normal physiologic bone turnover; however, they also destroy bone in osteoporosis, rheumatoid arthritis, and periodontal disease. Osteoclastogenesis (osteoclast formation) involves migration of precursor cells followed by cell fusion, both processes requiring a dynamic actin cytoskeleton. The protein filamin A has been shown in other cell types to control the actin cytoskeleton and cell migration, thus it may play a crucial role in osteoclastogenesis as well. Bisphosphonates are the current drug of choice to treat pathological bone destruction by inhibiting osteoclastogenesis, thus slowing down bone destruction and disease progression. However, due to impaired bone turnover and the resultant alteration in normal bony architecture, significant side effects of bisphosphonate therapy include poor bone healing and osteonecrosis (death of the bone) following traumatic events such as bone fractures and tooth extractions, leading to great morbidity, pain, and decreased quality of life. These clinical findings highlight the importance of my proposed research project. The role of filamin A in osteoclastogenesis has not been studied in the literature. The goal of my project is to delineate components of the filamin A signaling cascade during osteoclast formation. Our lab has bred mice with osteoclast progenitors that genetically lack filamin A. We have also developed a well-characterized 6 day model to grow osteoclasts from these mice. Using these resources I will delineate the filamin A signaling cascade during the migration and fusion stages of osteoclastogenesis, including its localization, temporal expression, and interaction with other signaling proteins. With better understanding of how filamin A regulates osteoclastogenesis, new drug targets may be identified to treat pathological bone resorption with reduced side effects.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Leung, Roland
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $165,000~ $0~